UIHLEIN RICHARD E received a stock award from GALECTIN THERAPEUTICS INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/21/2026ACC: 0001133416-26-000020
Director10% Owner
Since Jan 2019
+73.16K
Net shares
Net buyer
$40.0K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
73.16K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+13.16K
Price / share
$3.04
Trade value
$40K
% of position
0.1%
1/16/2026
10.32M→10.33M
Total
Net shares
+13.16K
Net value
$40K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/16/2026 | A · Award | +13.16K | $3.04 | $40K | 0.1% | 10.32M | 10.33M |
| Total | +13.16K | $40K | ||||||
Derivative Transactions1
Stock option (right to buy)
Direct
Converts to
Common Stock
60K shares
Shares
+60K
Strike price
3.04
Held after
60K
Exercisable
—
1/16/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock option (right to buy) Direct | Common Stock60K shares | 1/16/2026 | A · Award | +60K | 3.04 | — | 60K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned27.71K
Total
27.71K indirect27.71K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 27.71K | Indirect |
| Total | 27.71K | 27.71K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported